In both models, isoliensinine showed reduced tumor growth through the apoptosis of tumor cells mediated by increased caspase-3 activity, decreased levels of Bcl-2, Bcl-xL, and MMP-9, and decreased NF-κB p65 phosphorylation [117]. This evidence concerns the gene BCL2 and neoplasm.